Chase is responsible for the maintenance, operations and expansion of the facilities and infrastructure at Life Edit Therapeutics.
Chase started his career doing microbial fermentation process development for Novozymes. A passion for infrastructure and equipment engineering inspired a move into a traditional project engineering role with Medicago, a vaccine manufacturer. Chase has worked in various facilities and engineering roles across the vaccine and gene therapy industry since then.
Chase holds a B.S. in Bioprocess Engineering from Cornell University.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
